ALPHA.1-PROTEINASE INHIBITOR HUMAN

3272 reported adverse events

Drug classes: Human alpha-1 Proteinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ALPHA.1-PROTEINASE INHIBITOR HUMAN:

# Side effect Count
0 PNEUMONIA 515
1 DYSPNOEA 501
2 PRODUCT DOSE OMISSION ISSUE 402
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 300
4 DEATH 292
5 FATIGUE 276
6 COUGH 264
7 HEADACHE 247
8 COVID-19 234
9 FALL 213
See all common reactions for ALPHA.1-PROTEINASE INHIBITOR HUMAN

ALPHA.1-PROTEINASE INHIBITOR HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALPHA-1 ANTITRYPSIN DEFICIENCY 17 0.1932
1 OXYGEN SATURATION ABNORMAL 62 0.0218
2 INSURANCE ISSUE 184 0.0120
3 INFUSION SITE BRUISING 24 0.0111
4 POOR VENOUS ACCESS 98 0.0095
5 OBSTRUCTION 34 0.0085
6 MULTIPLE ALLERGIES 48 0.0061
7 RESPIRATORY TRACT INFECTION 152 0.0058
8 ADENOVIRUS INFECTION 15 0.0052
9 INFUSION SITE HAEMORRHAGE 16 0.0049
See all enriched reactions for ALPHA.1-PROTEINASE INHIBITOR HUMAN